Equities

Hanyuan Biotech International Inc

TNPH:PKL

Hanyuan Biotech International Inc

Actions
  • Price (USD)0.0066
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change--
  • Beta-0.8416
Data delayed at least 15 minutes, as of Dec 27 2023.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Hanyuan Biotech International Inc, formerly Tian’an Pharmaceutical Co Ltd, is a China-based company mainly engaged in research and developing (R&D), manufacturing and selling of Chinese medicine herbal products for the treatment and prevention of diseases.

  • Revenue in USD (TTM)10.65m
  • Net income in USD3.14m
  • Incorporated2005
  • Employees--
  • Location
    Hanyuan Biotech International Inc2/F No. 18 BuildingHuoju Road, East Development ZoneXI'AN 00000ChinaCHN
  • Phone+86 2 985381586
  • Websitehttp://www.xatazy.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Health Advance Inc-100.00bn-100.00bn464.87k3.00--0.1182----------0.0212----------------------------0.0356--100.00---21.75------
Drazcanna Inc2.05m-5.71m477.58k--------0.2333-0.7024-0.70240.24920.10040.685--23.88---191.19---643.20---11.20---279.10-----33.040.2445--------------
Meso Numismatics Inc2.44m-10.10m524.75k1.00------0.215-0.8113-0.81130.1959-1.900.438--33.37---181.33-192.08----69.9760.24-413.98-821.49---0.1106----57.49116.97-76.03--149.35--
Hanyuan Biotech International Inc10.65m3.14m539.39k--0.02940.00640.14810.05060.22460.22460.76111.03----------------68.54--29.51--13.3625.660.00--50.51--106.71------
NovAccess Global Inc0.00-1.74m546.38k1.00---------0.1193-0.11930.00-0.22460.00----0.00-1,836.30-2,185.89-------------------------177.93------
Pharmagreen Biotech Inc1.56k-500.66k597.28k0.00------382.87-0.0011-0.00110.00-0.00450.0094--3.35---302.10-472.20----11.54---32,096.15--0.0194-71.71--------80.68------
Molecular Pharmacology (USA) Ltd0.00-105.18k599.73k0.00---------0.0009-0.00090.00-0.01880.00-------976.60-1,219.29------------------------44.29------
Limitless X Holdings Inc14.21m-8.40m636.40k12.00------0.0448-2.10-2.103.58-3.513.731.7714.401,184,068.00-220.35------77.76---59.15--0.0173-9.02-----65.83---60.80------
Emo Capital Corp-100.00bn-100.00bn639.85k0.00---------------0.0017-----------7,495.00-------------------------138.44------
International Stem Cell Corp7.83m-327.00k644.35k29.00------0.0823-0.0409-0.04090.97850.00451.462.5311.87270,069.00-5.81-29.22-68.13-73.8258.5859.49-3.97-21.010.4672-6.060.9898---4.78-6.8260.42---34.45--
Capstone Holding Corp0.00-358.00k646.20k2.00---------6.58-38.120.00-60.700.00-------113.46141.94-199.60173.06-----------2.92--------52.46------
Bespoke Extracts Inc785.45k-1.48m647.74k10.00------0.8247-0.1458-0.14580.0774-0.16962.0655.9934.7378,545.00-388.21------43.69---188.79--0.0612-135.42----22,933.72--63.98------
Data as of Dec 27 2023. Currency figures normalised to Hanyuan Biotech International Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.